4.0 Article

Inhibition of carbonic anhydrase IX as a novel anticancer mechanism

期刊

WORLD JOURNAL OF CLINICAL ONCOLOGY
卷 3, 期 7, 页码 98-103

出版社

BAISHIDENG PUBLISHING GROUP INC
DOI: 10.5306/wjco.v3.i7.98

关键词

Carbonic anhydrase; Hypoxia; Sulfonamides; Coumarins; Tumorigenesis; Tumor imaging; Tumor acidification

类别

资金

  1. European Union Metoxia

向作者/读者索取更多资源

Carbonic anhydrases (CA, EC 4.2.1.1) catalyze the interconversion bewteen carbon dioxide and bicarbonate with generation of protons. The carbonic anhydrase isozyme IX (CA IX) is highly overexpresed in hypoxic tumors and shows very restricted expression in normal tissues. CA IX is a dimeric protein possessing very high catalytic activity for the hydration of carbon dioxide to protons and bicarbonate. Its quaternary structure is unique among members of this family of enzymes, allowing for structure-based drug design campaigns of selective inhibitors. Inhibition of CA IX with sulfonamide and/or coumarin inhibitors was recently shown to lead to a potent retardation for the growth of both primary tumors and metastases. Some fluorescent sulfonamides were shown to accumulate only in hypoxic tumor cells overexpressing CA IX, and might be used as diagnostic tools for imaging of hypoxic cancers. Sulfonamide inhibitors were also more effective in inhibiting the growth of the primary tumors when associated with irrdiation. CA IX is thus both a diagnostic and therapeutic validated target for the management of hypoxic tumors normally non-responsive to classical chemio- and radiotherapy. (C) 2012 Baishideng. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据